Encompass Health stock

EHC · NYSE · USD

Compare Encompass Health
$133.65Change from previous close: +1.04%Absolute change: +$1.37

Close · November 20, 2026

Price history

+18.49% over the period

1 year: from $112.79 (November 20, 2025) to $133.65 (November 20, 2026), +18.49%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$133.65
October 30, 2026$135.90
September 30, 2026$121.49
August 31, 2026$120.21
July 31, 2026$111.07
June 30, 2026$101.08
May 29, 2026$105.85
April 30, 2026$100.00
March 31, 2026$96.73
February 27, 2026$107.88
January 30, 2026$94.53
December 31, 2025$106.14
November 28, 2025$116.22
November 20, 2025$112.79

At a glance

  • The company

    Operates inpatient rehabilitation hospitals across the United States and Puerto Rico, providing specialized therapies and medical care for recovery from major injuries and illnesses

  • Latest results

    Quarter to September 30, 2026 · EPS $1.52 (estimate $1.36)

TickerLandia's take on Encompass Health

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$92.77
52-wk high$143.90

−7.12% from the 52-week high

Analysts · 13 analysts

Average target$156.08+16.79% vs. price

Buy 13 · Hold 0 · Sell 0

TickerLandia Fingerprint: Encompass Health

Compared with similar companies: very strong momentum.

Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 888 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Encompass Health is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), Encompass Health's P/E today is 24.1, above the median of its last 10 fiscal years (18.0; between 12.6 and 23.1 from 2016 to 2025). Encompass Health's P/E (trailing 12 months): 21.4, +26% against the median of a group of 11 similar companies (16.9).

P/E compared with its history

Compared with 11 similar companies

Encompass Health's metrics compared with similar companies
MetricEncompass HealthPosition in the groupBand
P/E (trailing 12 months)21.4Middle
Forward P/E19.4Middle
Operating margin18.4%Middle
ROE25.1%High
Debt/equity0.79Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Encompass Health. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$1.61B

Latest quarter · Q3 2026

Net income

$149.9M

Latest quarter · Q3 2026

Quarterly net margin

9.3%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$13.11B
P/E
21.4
EPS
$6.25
Volume
911.93K
Daily trading
€134.93M
Dividend yield
0.58%

How Encompass Health is changing

All results
  • Revenue grew 10.7% a year on average over the last 5 years

  • Operating margin rose from 12.4% to 17.7%

  • Free cash flow equal to 78% of net income

Returns

Encompass Health returns with dividends

$1,000 invested in Encompass Health 5 years ago, on November 22, 2021, would be worth $2,800 today with dividends reinvested: +180.05% in total, +22.90% per year. On price alone it would be $2,662 (+166.24%).

PeriodEncompass HealthS&P 500$1,000 becomes
1 month+9.85%−10.40%$1,098
6 months+26.10%−7.03%$1,261
Year to date+25.92%+0.95%$1,259
1 year+19.37%+5.68%$1,194
3 years+110.26%+51.96%$2,103
5 years+180.05%+47.57%$2,800
10 years+372.35%+214.37%$4,723

Over the last 6 months it has done better than 71% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Encompass Health: technical analysis

Encompass Health is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 6.2% below its highest close since January 2, 1990 ($142.51, November 10, 2026).

Trend
Upward
RSI (14 sessions)
50
Between 30 and 70
vs 200-session average
+18.12%

Support and resistance

Price areas where Encompass Health has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price$133.65
  3. Support$118.22−11.54%8 touches, last on October 20, 2026
  4. Support$109.27−18.24%7 touches, last on July 31, 2026
  5. Support$106.15−20.57%4 touches, last on July 14, 2026

Volatility and risk

Over the last year it has moved little with the S&P 500.

Beta (1 year) vs S&P 500
0.00
Volatility (60 sessions, annualised)
30.5%
Largest fall in the last year
−19.29%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Encompass Health: seasonality

Average monthly price change over 37 years

+0.0%Jan−0.6%Feb−1.3%Mar+7.1%Apr+3.7%May+2.5%Jun+6.3%Jul+1.8%Aug−2.2%Sep+0.7%Oct+5.2%Nov+5.3%Dec

Over the last 37 years, the strongest month for Encompass Health has been April: +7.14% on average, positive in 28 years out of 37. The weakest has been September: −2.16% on average, positive in 18 years out of 37. November, the current month, has been positive in 25 years out of 36 (+5.22% on average).

Show chart data
MonthAverageMedianPositive years
January+0.02%+2.57%19 of 36
February−0.61%+0.68%21 of 37
March−1.31%+1.16%23 of 37
April+7.14%+5.23%28 of 37
May+3.69%−0.47%18 of 37
June+2.49%0.00%18 of 37
July+6.27%−0.28%18 of 37
August+1.80%+0.12%19 of 37
September−2.16%−0.34%18 of 37
October+0.67%−1.45%16 of 37
November+5.22%+3.09%25 of 36
December+5.33%+2.64%23 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Encompass Health and its competitors

Inpatient rehabilitation care is the core of the business of Encompass Health Corporation, which runs its facilities across the United States and in Puerto Rico. Patients admitted for rehabilitation after a stroke, a brain or spinal cord injury, cardiac or pulmonary conditions, complex orthopedic problems or an amputation receive therapy supported by medical, nursing and ancillary services, with the aim of regaining mobility, independence and quality of life. Payers include the Medicare program, managed care plans, private insurers, state governments and individual patients.

Headquarters
Birmingham, United States
Employees
29,875
Founded
1983
Chief executive
Mark Tarr
Encompass Health and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Encompass HealthEHC$13.11B18.4%21.4+26.10%
Universal Health ServicesUHS$10.34B10.9%7.51+9.20%
Ensign GroupENSG$10.29B8.8%26.2−1.09%
DavitaDVA$10.13B15.2%12.2−18.20%
Tenet HealthcareTHC$20.95B19.1%7.68+40.44%
HCA HealthcareHCA$99.34B15.3%15.8+19.89%

Same industry or related industries, similar size. Compare Encompass Health with its competitors · Full profile